SPY314.57-1.61 -0.51%
DIA258.49-2.23 -0.86%
IXIC10,519.98+27.48 0.26%

Guggenheim Maintains Buy on BeiGene, Raises Price Target to $228

Guggenheim maintains BeiGene (NASDAQ:BGNE) with a Buy and raises the price target from $205 to $228.

Benzinga · -

Guggenheim maintains BeiGene (NASDAQ:BGNE) with a Buy and raises the price target from $205 to $228.